Jonathan Keller

Jonathan Keller has a robust background in pharmaceutical sales and market access, currently serving as Associate Director and Market Access Strategic Account Manager in the Radioligand Therapy Division at Novartis since October 2022. Previously, Jonathan worked as an Oncology Territory Manager at Eisai US from July 2021 to October 2022 and held multiple roles at AbbVie from December 2012 to July 2021, including Account Executive with a focus on Urology and Oncology Specialty Sales. Early career experience includes positions in specialty sales at Solvay Pharmaceuticals and Abbott, along with a Professional Sales Representative role at NextWave Pharmaceuticals from 2006 to 2008. Jonathan Keller obtained a degree from the University of Iowa between 2002 and 2005.